Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Lantus and NPH Insulin in the Dawn Phenomenon

NCT00694122 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00694122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00694122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Lantus and NPH Insulin in the Dawn Phenomenon
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2005
Completion date
November 30, 2010
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dawn phenomenon, type 1 diabetes